Scott Kopetz, Rocio Garcia-Carbonero, Sae-Won Han, Ildefonso Ismael Rodriguez Rivera, Jose Carlos Ruffinelli, Valentina Boni, Maria Vieito Villar, Maria J. de Miguel, Athanasios G. Pallis, Christina Habermehl, Abdul Siddiqui, Abhigyan Ravula, Ken Kato. "Precemtabart tocentecan (M9140), an anti-CEACAM5 ADC with exatecan payload, in patients with metastatic colorectal cancer (mCRC): Results from the dose optimization of the phase 1 PROCEADE CRC-01 study.." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.3038